Updated:
BlueTree Venture Fund
Early stage venture capital firm focused on compelling tech opportunities from PA, NC, IL, CA, and AZ | The BlueTree Venture Fund is a regionally-focused...
BlueTree Venture Fund
Early stage venture capital firm focused on compelling tech opportunities from PA, NC, IL, CA, and AZ | The BlueTree Venture Fund is a regionally-focused venture capital firm based in Pittsburgh, PA. We target early institutional investments in sectors which both match the region’s technology platform and leverage the expertise within our Fund. We seek to invest in medical technologies, software, and high-tech instrumentation companies located within 250 miles, allowing us to provide hands on mentorship and guidance.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Wexford
Corporate office
Wexford, PA, United States
Principals
Catherine Mott
CEO and Founder
Michael Fink
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at BlueTree Venture Fund?
Catherine Mott, the founder and CEO, leads the investment committee and sets strategy. Managing Director Michael Fink and a select group of venture partners contribute to sourcing, diligence, and portfolio governance. The firm deliberately maintains a flat decision-making structure consistent with its lean team size and concentrated portfolio model.
How does BlueTree source proprietary deal flow?
BlueTree relies on a deeply embedded network within the Pittsburgh-to-Midwest corridor, drawing on Catherine Mott's banking background and long-standing ties to the Angel Capital Association. The firm prospects through regional accelerators, university spinouts, and founder referrals rather than competing in broadly marketed processes. This local-network model yields a pipeline of companies that rarely appear on coastal VC radars.
Is BlueTree structured as a venture capital firm or does it operate more like an angel syndicate?
BlueTree is a formal venture capital firm that raises committed institutional funds, not an ad-hoc syndicate. It leads and co-leads priced seed rounds and takes board seats. That said, Mott's parallel involvement with angel networks does inform the firm's syndication patterns, and some BlueTree deals include co-investment from accredited individuals within those networks.
Does BlueTree participate in fund commitments or only direct deals?
BlueTree deploys capital exclusively through direct investments into operating companies. There is no indication from available public records or fund descriptions that the firm commits as a limited partner to other venture funds, distinguishing it from a fund-of-funds or hybrid allocator model.
What investment stages does BlueTree typically target?
Seed and early-stage rounds, with a preference for being the first institutional investor. The firm occasionally participates in Series A follow-on financings for existing portfolio companies. Public disclosures do not suggest meaningful late-stage, growth-equity, or pre-IPO activity.
How does BlueTree's geographic focus affect its portfolio construction?
The firm concentrates on the Mid-Atlantic and Midwest — principally Western Pennsylvania, Ohio, and adjacent states. This regional lock means the portfolio is intentionally exposed to sectors where those geographies have comparative strengths: advanced manufacturing, industrial automation, and enterprise software servicing legacy-industry customers. The trade-off is a smaller addressable market of venture-backable companies compared to coastal funds.
What is Catherine Mott's background, and how does it shape BlueTree's investment approach?
Mott came to venture through a career in commercial banking rather than through operating a startup or inheriting wealth. This banking lens shapes BlueTree's emphasis on capital efficiency, customer-backed revenue models, and financial governance. Her parallel leadership role in the Angel Capital Association has made syndication discipline a core competency of the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: